GP combination therapy for treatment of 50 patients with advanced non-small cell lung cancer
- VernacularTitle:GP方案治疗50例晚期非小细胞肺癌的疗效观察
- Author:
Guoxiang LIU
;
Heping YANG
;
Wei XIONG
;
- Publication Type:Journal Article
- Keywords:
lung cancer;
non small cell lung cancer;
gemcitabine;
drug therapy;
chemotherapy
- From:Journal of Third Military Medical University
2003;0(18):-
- CountryChina
- Language:Chinese
-
Abstract:
0 05). The median duration of survival was 8 5 months, and 1 year survival rate was 32 2%. Toxicity was chiefly hematologic in the form of neutropenia. The major non hematologic toxicity was nausea or vomiting. Conclusion The GP combination chemotherapy is an active regimen for the advanced NSCLC with tolerable toxicity.
